Advancing Measurable Residual Disease Detection in Pediatric BCP-ALL: Insights from Novel Immunophenotypic Markers.

Int J Mol Sci · 2025 · PMC12072110 · PMID 40362518

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Differential expression of CD58, CD304, and CD73 in diagnostic samples was highly significant ( p < 0.01) between pre-B-I, pre-B-II, immature B cells, and BCP-ALL blasts.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.